return equiti ttm
make minor updat estim zoeti follow compani first-
quarter earn releas wednesday morn overal quarter
updat full-year guidanc gener line expect detail
quarter compar estim see first look first-quart result
straightforward quarter guidanc reduc maintain ep target
pandem clearli impact new product launch crimp
overal market growth chang view zoeti continu best-
posit compani anim health manufactur space longer term
potenti larger contribut newer aspect portfolio
diagnost precis livestock maintain outperform rate zoeti given
stabil busi model despit heighten valuat
companion anim compani note in-offic visit
in-offic visit europ earli april roughli line
modestli wors outperform recent report
publish past week track state veterinari
healthcar space week end may howev manag note dynam
turn around quickli signific improv
europ sinc apoquel cytopoint combin million revenu
first quarter year-over-year increas see exhibit believ room
continu momentum despit current macro challeng compani lower
simparica trio expect due rang million million
compar million previous believ long-term outlook product
quit good though challeng detail vet product present make
difficult entri market
livestock think progress lack thereof around disrupt anim
protein process meat pack capac key zoetiss busi
next month compani indic process capac
roughli lower typic level present even hear processor
start thu far tend lower output level given
safeti precaut increas employe absente produc handl short-
term disrupt longer challeng extend like becom
produc reduc cattl herd size lesser extent number hog
therefor urg investor close monitor fluid situat exhibit
zoeti leader develop manufactur market anim health medicin vaccin
product companion anim market annual revenu exceed billion compani found
divis spun februari oper countri maintain one
largest budget industri
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
exhibit companion anim organ growth geographi present
exhibit quarterli apoquel cytopoint sale present
exhibit livestock organ growth speci present
xxsourc compani report william blair equiti compani compani report william blair equiti william blair
exhibit livestock organ growth geographi present
increas revenu estim million billion maintain
ep estim result higher-than-expect interest expens
decreas ep target reflect higher interest expens organ
revenu growth assumpt unchang next year
valuat stock thought
zoeti trade time updat ep estim compar post-ipo averag
time forward earn anim health manufactur peer time high-growth diagnost peer
time continu impress manag steadi execut innov flow thu reiter
outperform rate despit expand valuat summari revis model found exhibit
view follow key risk zoeti next three five year slowdown economi neg
affect spend companion anim livestock diseas outbreak shift away usag antibiot food
anim shift away meat consumpt develop market due chang consum prefer
xxsourc compani report william blair equiti william blair
good gross gener research amort intang total oper oper expense/ incom pre-tax tax net loss attribut non-controlling interest- net incom excl non-recurring non-recurring item net net ep excl non-recurring per average share outstand margin analysi gross metric total revenu constant oper revenu constant incom excl non-recur excl non-recur share blair compani estimatesourc compani report william blair equiti research import disclosur
william blair affili market maker secur zoeti inc
william blair affili expect receiv intend seek compens invest bank servic zoeti inc affili
within next three month
offic employe william blair affili research analyst may financi interest secur zoeti
inc report avail electron form regist user via doc http //williamblairlibrari bluematrix com
pleas contact us consult williamblair com/research-and-insights/equity-research/coverag aspx disclosur
